Moonlight Therapeutics completes pre-IND meeting with FDA

ATLANTA (Jan 18, 2022) (PRWEB) January 18, 2022 -- Moonlight Therapeutics Completes Pre-IND Meeting With FDA for MOON101 for Peanut Allergy

Related Keywords

United States ,Georgia ,Texas ,Atlanta ,Brian Vickery ,Samir Patel ,Moonlight Therapeutics Inc ,Food Allergy Center At Emory ,Texas Tech University ,Drug Administration ,Georgia Research Alliance ,Moonlight Therapeutics ,Investigational New Drug Application ,Food Allergy Center ,Georgia Research ,Press Release ,